CompanyGraph
Integral Diagnostics Ltd
IDX · ASX · Australia
Price data from its IDX listing on CXA
integraldiagnostics.com.auFinancials as of FY2025
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleRevenue is $540.84M, above the global median of $520.53M
- PositionCurrent ratio is 0.63×, lower than 95% of its Diagnostics & Research peers (median 2.44×)
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
3.17%Above 5Y avg (2.53%)
Annual Rate
AUD 0.07Paid semi-annual
Payout Ratio
156.6%High
Last Ex-Dividend
Mar 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
783.44MAUD551.84M · vs all stocks (USD)
Trailing P/E
52.50xvs Diagnostics & Research peers
Revenue (TTM)
767.82MAUD540.84M · vs all stocks (USD)
Profit Margin
1.83%vs Diagnostics & Research peers
Beta
0.1200xvs all stocks
52-Week Change
-21.64%vs all stocks
Forward Annual Dividend Yield
3.17%vs all stocks
Market Capitalization
783.44MAUD551.84M · vs all stocks (USD)
Enterprise Value
1.35BAUD952.75M · vs all stocks (USD)
Trailing P/E
52.50xvs Diagnostics & Research peers
Forward P/E
14.01xvs Diagnostics & Research peers
Price to Sales (TTM)
1.02xvs Diagnostics & Research peers
Price to Book (MRQ)
1.15xvs Diagnostics & Research peers
Enterprise to Revenue
1.76xvs Diagnostics & Research peers
Enterprise to EBITDA
12.67xvs Diagnostics & Research peers
Profit Margin
1.83%vs Diagnostics & Research peers
Operating Margin
8.47%vs Diagnostics & Research peers
Return on Assets (TTM)
3.18%vs Diagnostics & Research peers
Return on Equity (TTM)
2.06%vs Diagnostics & Research peers
Revenue (TTM)
767.82MAUD540.84M · vs all stocks (USD)
Revenue per Share (TTM)
2.08AUDUpdated Jul 19, 2026Quarterly Revenue Growth
55.60%vs Diagnostics & Research peers
Gross Profit (TTM)
241.84MAUD170.35M · vs all stocks (USD)
EBITDA (TTM)
88.24MAUD62.15M · vs all stocks (USD)
Net Income (TTM)
14.03MAUD9.88M · vs all stocks (USD)
Operating Cash Flow (TTM)
84.69MAUD59.65M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
39.56MAUD27.87M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0660AUDUpdated Jul 19, 2026Forward Annual Dividend Yield
3.17%vs all stocks
Trailing Annual Dividend Rate
0.0730AUDUpdated Jul 19, 2026Trailing Annual Dividend Yield
3.51%vs all stocks
5-Year Average Dividend Yield
2.53%vs all stocks
Payout Ratio
156.63%vs Diagnostics & Research peers
Minority Interest (Equity)
942.00KAUDFY2025 · Jun 30, 2025Revenue
627.22MAUDFY2025 · Jun 30, 2025Cost of Goods Sold
28.13MAUDFY2025 · Jun 30, 2025Gross Profit
599.09MAUDFY2025 · Jun 30, 2025Operating Income
57.53MAUD40.53M · vs all stocks (USD)
Pre-tax Income
11.65MAUDFY2025 · Jun 30, 2025Income Tax Expense
6.84MAUDFY2025 · Jun 30, 2025Net Income
4.82MAUDFY2025 · Jun 30, 2025EBIT
31.16MAUDFY2025 · Jun 30, 2025EBITDA (Income Statement)
88.24MAUDFY2025 · Jun 30, 2025Selling, General & Administrative
418.16MAUDFY2025 · Jun 30, 2025Other Operating Expenses
66.86MAUDFY2025 · Jun 30, 2025Non-operating Interest Income
1.09MAUDFY2025 · Jun 30, 2025Non-operating Interest Expense
19.51MAUDFY2025 · Jun 30, 2025EPS (Basic)
0.0160AUDFY2025 · Jun 30, 2025EPS (Diluted)
0.0160AUDFY2025 · Jun 30, 2025Basic Shares Outstanding
306.62MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
306.62MSharesFY2025 · Jun 30, 2025Minority Interests (P&L)
-146.00KAUDFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
52.10MAUDFY2025 · Jun 30, 2025Income Tax Paid
4.00MAUDFY2025 · Jun 30, 2025Interest Paid
30.73MAUDFY2025 · Jun 30, 2025Capital Expenditures
-59.45MAUDFY2025 · Jun 30, 2025Net Acquisitions
-5.55MAUDFY2025 · Jun 30, 2025Net Investing Cash Flow
-64.99MAUDFY2025 · Jun 30, 2025Long-term Debt Issuance
343.38MAUDFY2025 · Jun 30, 2025Long-term Debt Payments
-308.27MAUDFY2025 · Jun 30, 2025Common Dividends Paid
-15.46MAUDFY2025 · Jun 30, 2025Other Financing Charges
-18.94MAUDFY2025 · Jun 30, 2025Net Financing Cash Flow
710.00KAUDFY2025 · Jun 30, 2025Shares Outstanding
372.22MSharesUpdated Jul 19, 2026Float Shares
339.16MSharesUpdated Jul 19, 2026% Held by Insiders
5.49%vs all stocks
% Held by Institutions
46.91%vs all stocks
Total Cash (MRQ)
34.12MAUD24.04M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0920AUDUpdated Jul 19, 2026Total Debt (MRQ)
601.39MAUD423.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8822xvs Diagnostics & Research peers
Current Ratio (MRQ)
0.6270xvs Diagnostics & Research peers
Book Value per Share (MRQ)
1.82AUDUpdated Jul 19, 2026Total Assets
1.43BAUD1.00B · vs all stocks (USD)
Total Current Assets
95.28MAUDFY2025 · Jun 30, 2025Total Liabilities
732.53MAUDFY2025 · Jun 30, 2025Total Non-current Assets
1.33BAUDFY2025 · Jun 30, 2025Total Non-current Liabilities
591.87MAUDFY2025 · Jun 30, 2025Total Current Liabilities
140.66MAUDFY2025 · Jun 30, 2025Cash
52.10MAUDFY2025 · Jun 30, 2025Cash & Cash Equivalents
52.10MAUDFY2025 · Jun 30, 2025Accounts Receivable
30.08MAUDFY2025 · Jun 30, 2025Inventory
2.52MAUDFY2025 · Jun 30, 2025Accounts Payable
20.59MAUDFY2025 · Jun 30, 2025Short-term Debt
20.32MAUDFY2025 · Jun 30, 2025Deferred Revenue
2.67MAUDFY2025 · Jun 30, 2025Other Current Liabilities
8.45MAUDFY2025 · Jun 30, 2025Long-term Debt
564.68MAUDFY2025 · Jun 30, 2025Other Non-current Liabilities
486.00KAUDFY2025 · Jun 30, 2025Common Stock (Book)
735.40MAUDFY2025 · Jun 30, 2025Retained Earnings
-37.13MAUDFY2025 · Jun 30, 2025Total Shareholders' Equity
693.94MAUD488.80M · vs all stocks (USD)
52-Week Low
1.91AUDUpdated Jul 19, 202652-Week High
3.07AUDUpdated Jul 19, 202652-Week Change
-21.64%vs all stocks
Beta
0.1200xvs all stocks
50-Day MA
2.07AUDUpdated Jul 19, 2026200-Day MA
2.37AUDUpdated Jul 19, 2026Avg 10-Day Volume
724.85KSharesUpdated Jul 19, 2026Avg 30-Day Volume
1.24MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.0400AUDUpdated Jul 19, 2026Other Income / Expense
-18.07MAUDFY2025 · Jun 30, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.63×, lower than 95% of its Diagnostics & Research peers (median 2.44×)Significant
Current ratio: 0.63Industry median: 2.44Industry P5: 0.70Peers compared: 31.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.57Dividend per Share: 0.07Earnings per Share: 0.04
Financial Health
Altman Z-Score 1.08: distress zoneCritical
Altman Z-Score: 1.08
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $540.84M, above the global median of $520.53MNotable
Revenue (USD): 540,838,471.63Global Median: 520,528,949.311
Levered free cash flow is $27.87M, above the global median of $16.24MNotable
Levered free cash flow (USD): 27,868,177.663Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Fuxin Dare Automotive Parts Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Asahi Yukizai Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Smart Control Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Alton Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Comens New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Ningbo Solartron Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Tianan New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Sri Trang Agro-Industry Public Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Dinghan Technology Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Malibu Boats Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk